Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism

Thromb Haemost 2010; 104(01): 189-190
DOI: 10.1160/TH10-01-0076

Letters to the Editor

Schattauer GmbH

Frederikus A. Klok

¹Section of Vascular Medicine, Department of General Internal Medicine-Endocrinology, LUMC, Leiden, the Netherlands

,

Noortje van der Bijl

²Department of Radiology, LUMC, Leiden, the Netherlands

,

Inge C. M. Mos

¹Section of Vascular Medicine, Department of General Internal Medicine-Endocrinology, LUMC, Leiden, the Netherlands

,

Albert de Roos

²Department of Radiology, LUMC, Leiden, the Netherlands

,

Lucia J. M. Kroft

²Department of Radiology, LUMC, Leiden, the Netherlands

,

Menno V. Huisman

¹Section of Vascular Medicine, Department of General Internal Medicine-Endocrinology, LUMC, Leiden, the Netherlands

References
1 Torbicki A, Perrier A, Konstantinides S. et al Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
2 Aujesky D, Hughes R, Jiménez D. Short-term prognosis of pulmonary embolism. J Thromb Haemost 2009; 07 (Suppl. 01) (Suppl) 318-321.
3 Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008; 178: 425-430.
4 Hama N, Itoh H, Shirakami G. et al Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995; 92: 1558-1564.
5 Klok FA, van der Bijl N, Eikenboom HCJ. et al Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short term clinical outcome in normotensive patients suspected for having acute pulmonary embolism. J Thromb Haemost 2010; 08: 853-856.